Sequire Spotlight Presents: Biostem (BSEM) – Harnessing the Natural Properties of Placenta Tissues
November 20, 2024
Biotechnology
-
-
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer
November 20, 2024
-
Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC
November 19, 2024
-
Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger
November 11, 2024
-
Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
November 11, 2024
-
Ocugen Secures $30 Million in Debt Funding
November 7, 2024
-
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
November 6, 2024
-
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 5, 2024
-
Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 5, 2024
-
NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement
November 4, 2024
-
Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger
November 4, 2024
-
Scorpius Holdings Announces Partnership with U.S. Biotech Company
October 22, 2024
-
Quoin Pharmaceuticals Announces Further International Expansion of Ongoing Clinical Trials for Netherton Syndrome
October 22, 2024
-
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
October 21, 2024
-
Kane Biotech Announces Exclusive Distribution Agreement With XSONX
October 17, 2024
-
XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
October 17, 2024